Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 90 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
891 12.6 months NSCLC 5 Biologic therapy
Chemotherapy
Robert H. Lurie Comprehensive Cancer Center United States 12/2013
Treatment Details: Patients: This phase 3 study involved nonsquamous non-small cell lung cancer patients who were divided into two separate treatment groups. Group A consisted of 472 patients with a median ag
 
892 12.6 months Metastatic urothelial carcinoma 4 Chemotherapy
Istituto Neurotraumatologico Italiano Italy 12/2011
Treatment Details: Patients: This phase 2 trial involved 44 previously treated metastatic urothelial carcinoma patients with a median age of 64 years; 83% were male. Treatment: Patients were treated with
 
893 12.6 months GBM 4 Biologic therapy
Lee Moffitt Cancer Center and Research Institute United States 10/2012
Treatment Details: Patients: This phase 2 study involved recurrent malignant glioma patients who were separated into different groups based on the specific type of cancer they had. There were 14 patients wit
 
894 12.6 months NHL 5 Biologic therapy
Chemotherapy
Hormone
The Royal Marsden NHS Foundation Trust United Kingdom 7/2014
Treatment Details: Patients: This study involved 45 relapsed diffuse large B-cell lymphoma patients with a median age of 58 years; 64% were male. Treatment: Patients received chemotherapy with gemcitabine
 
895 12.5 months Metastatic transitional cell carcinoma of the bladder 4 Chemotherapy
Mansoura University Egypt 8/2012
Treatment Details: Patients: This phase 2 study involved 40 patients with metastatic transitional cell carcinoma of the bladder who had previously received cisplatin-gemcitabine chemotherapy. The median pati
 
896 12.5 months GBM 4 Chemotherapy
Radiation
Sant' Andrea Hospital Italy 10/2014
Treatment Details: Patients: This study involved 127 elderly, newly diagnosed glioblastoma patients. The median patient age was 68 years (range of 65-76) and 56% were male. Treatment: Patients received r
 
897 12.5 months Metastatic colorectal cancer 5 Chemotherapy
Antwerp University Hospital Belgium 11/2010
Treatment Details: Patients: This phase III study involved patients with metastatic colorectal cancer who had previously received chemotherapy. Patients were divided into two separate treatment groups. Grou
 
898 12.5 months Epithelial ovarian cancer 5 Chemotherapy
Copenhagen University Hospital Denmark 10/2010
Treatment Details: Patients: This study involved 79 women with recurrent epithelial ovarian cancer with a median age of 59 years (range 31-77). Treatment: Patients were treated with two chemotherapy agent
 
899 12.5 months Hormone-refractory prostate cancer 4 Biologic therapy
Chemotherapy
Oregon Health Sciences University United States 9/2005
Treatment Details: Patients: This Phase I/II study involved 24 men with metastatic androgen-refractory prostate cancer. Metastatic sites included bone, lymph nodes, and viscera. The median age was 67 years.
 
900 12.5 months Advanced NSCLC 4 Chemotherapy
University of North Carolina, Chapel Hill United States 10/2002
Treatment Details: Patients: This Phase II trial involved 40 patients with advanced (stage IIIB or IV) non-small cell lung carcinoma. Treatment: The treatment consisted of a three-drug combination of irinot
 
Page 90 of 187  | Previous Page  | Next Page